Biovance Capital Partners
ABOUT BIOVANCE CAPITAL PARTNERS
Biovance Capital Partners is a Lisbon venture capital firm founded in 2023 and described as Portugal's first specialised biotech VC. It invests at Series A and later in life sciences and biotech companies with validated science and clear commercialization paths, writing tickets of €1.5M–€6M. Biovance Capital Partners launched Fund I at €57M in 2025 and is actively deploying, backed by the European Investment Fund (EIF), BIAL — Portugal's largest pharmaceutical company — and Banco Português de Fomento. That mix gives the firm both pharma sector depth and institutional support for later-stage life sciences bets. The team is led by Managing Partner Ricardo Perdigão Henriques, with General Partner João Incio and Non-Executive Partner Peter Villax. Having made two investments so far, its portfolio includes Mondego Bio and Laigo Bio. Biovance Capital Partners targets biotech companies post-Series A where the science is de-risked and the route to market is defined, using BIAL's expertise and EIF backing to support commercialization.
INVESTMENT THESIS
Later-stage life sciences investor. Targets biotech companies post-Series A with validated science and clear commercialization paths. BIAL's pharma expertise and EIF backing give it sector depth.
INVESTMENT DETAILS
TEAM
FREQUENTLY ASKED QUESTIONS
What stage does Biovance Capital Partners invest at?
Biovance Capital Partners invests at Series A+ stage.
What is Biovance Capital Partners's typical ticket size?
Biovance Capital Partners typically writes cheques of €1.5M–€6M.
What sectors does Biovance Capital Partners invest in?
Biovance Capital Partners focuses on Life Sciences, Biotech.
Where is Biovance Capital Partners based?
Biovance Capital Partners is a VC based in Lisbon, Portugal, founded in 2023.
Who are the partners at Biovance Capital Partners?
Key people at Biovance Capital Partners include Ricardo Perdigão Henriques (Managing Partner), João Incio (General Partner), Peter Villax (Non-Executive Partner).
What companies has Biovance Capital Partners invested in?
Biovance Capital Partners's portfolio includes Laigo Bio, Mondego Bio.
How much does Biovance Capital Partners manage?
Biovance Capital Partners manages €57M in assets / fund commitments.
Is Biovance Capital Partners actively investing?
Fund I €57M (2025), deploying.
How do I contact or pitch Biovance Capital Partners?
You can reach Biovance Capital Partners via their website (biovancecapital.com). You can also submit your startup through Portugal VC's pitch tool to be forwarded to matching investors.